Radium-223 dichloride treatment for prostate cancer with bone metastases: A symptomatic outcome review of 12 months experience

被引：0
|
作者：
Lee, H. H. [1 ]
McAddy, N. C. [1 ]
O'Sullivan, P. [1 ]
Crawley, P. [1 ]
Beesley, S. [2 ]
Naji, M. [1 ]
机构：
[1] Maidstone & Tunbridge Wells NHS Trust, Nucl Med Dept, Maidstone, Kent, England
[2] Maidstone & TunbridgeWells NHS Trust, Dept Oncol, Maidstone, Kent, England
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2016年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EPW18
引用
收藏
页码：S214 / S215
页数：2
相关论文
共 50 条
  • [11] Clinical experience with radium-223 in the treatment of patients with advanced castrate-resistant prostate cancer and symptomatic bone metastases
    Hague, Christina
    Logue, John P.
    THERAPEUTIC ADVANCES IN UROLOGY, 2016, 8 (03) : 175 - 180
  • [12] Radium-223 dichloride: a new paradigm in the treatment of prostate cancer
    Anido Herranz, Urbano
    Fernandez Calvo, Ovidio
    Afonso Afonso, Francisco Javier
    Martinez de Llano, Sofia Rodriguez
    Lazaro Quintela, Martin
    Leon Mateos, Luis
    Vazquez Estevez, Sergio
    Anton Aparicio, Luis Miguel
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (03) : 339 - 348
  • [13] NICE guidance on radium-223 dichloride for hormone-relapsed prostate cancer with bone metastases
    Umeweni, Nwamaka
    Knight, Helen
    McVeigh, Gary
    LANCET ONCOLOGY, 2016, 17 (03): : 275 - 276
  • [14] Efficacy and Safety of Radium-223 Dichloride in the Treatment of Patients with Castration-Resistant Prostate Cancer with Bone Metastases
    Sanchez Lopez, Hector
    GACETA MEXICANA DE ONCOLOGIA, 2016, 15 : 1 - 2
  • [15] ESTIMATING THE ECONOMIC IMPACT OF RADIUM RA 223 DICHLORIDE (RADIUM-223) IN TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER (CRPC) WITH SYMPTOMATIC BONE METASTASES AND NO KNOWN VISCERAL METASTATIC DISEASE
    Valderrama, A.
    Bilir, S. P.
    Wehler, E. A.
    Seal, B. S.
    Wen, L.
    Yaldo, A.
    Munakata, J.
    VALUE IN HEALTH, 2014, 17 (03) : A74 - A74
  • [16] Retrospective Toxicological Profiling of Radium-223 Dichloride for the Treatment of Bone Metastases in Prostate Cancer Using Adverse Event Data
    Soldatos, Theodoros G.
    Iakovou, Ioannis
    Sachpekidis, Christos
    MEDICINA-LITHUANIA, 2019, 55 (05):
  • [17] EMA guidance on radium-223 dichloride in prostate cancer
    Gourd, Elizabeth
    LANCET ONCOLOGY, 2018, 19 (04): : E190 - E190
  • [18] Residents' Guide to Radium-223 Dichloride Treatment For Metastatic Prostate Cancer
    Ersahin, Devrim
    Chen, Ming-Kai
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [19] The safety and efficacy of radium-223 dichloride for the treatment of advanced prostate cancer
    Wilson, James M.
    Parker, Christopher
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (09) : 911 - 918
  • [20] Radium-223 for the treatment of prostate cancer
    Hafeez, Shaista
    Parker, Christopher
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (03) : 379 - 387
12345